{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:23:40Z","timestamp":1793075020378,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003065","name":"University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mindfulness-based interventions (MBIs) are effective in improving mental and physical health in various chronic conditions. While the GOLD 2024 report recommends MBIs for chronic obstructive pulmonary disease (COPD), scientific evidence in this specific population is scarce. This prospective randomised controlled pilot study investigated the feasibility of an 8-week digital MBI and its preliminary effects on mental and physical health in COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Psychologically burdened COPD patients (63\u2009\u00b1\u20097 years, 61% female, FEV1% 41\u2009\u00b1\u200919) were randomly allocated to the MBI group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914; daily 10-15-minute audio-guided meditation via smartphone) or a waitlist control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916). Primary outcomes included the intervention\u2019s feasibility (dropouts, MBI usage rates, interview and questionnaire responses) and its preliminary effects on symptoms of anxiety and depression (Hospital Anxiety and Depression Scale, HADS). Secondary outcomes included its preliminary effects on the COPD Assessment Test (CAT), Chronic Respiratory Disease Questionnaire (CRQ-SAS), Perceived Stress Scale (PSS-10), and biological stress markers. Exploratory outcomes included momentary subjective stress, anxiety, and dyspnoea after meditating.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results indicated that the intervention was feasible (81% usage rate; 93% and 71% found the MBI enjoyable and helpful, respectively), with 21% dropout. A statistically significant intervention (time x group) effect was found for anxiety (HADS-A,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=.010,\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>p<\/jats:italic>\n                      <\/jats:sub>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20090.11) and emotional functioning (CRQ-SAS,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=.004,\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>p<\/jats:italic>\n                      <\/jats:sub>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20090.14), but not for depression (HADS-D,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=.060,\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>p<\/jats:italic>\n                      <\/jats:sub>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20090.06) or any other secondary outcome after 8 weeks. Momentary subjective stress (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;.001,\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>p<\/jats:italic>\n                      <\/jats:sub>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20090.75), anxiety (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=.022,\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>p<\/jats:italic>\n                      <\/jats:sub>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20090.75), and dyspnoea (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;.001,\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>p<\/jats:italic>\n                      <\/jats:sub>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      \u2009=\u20090.70) were significantly reduced after meditating.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The digital MBI was feasible, with preliminary effects indicating improvements in anxiety and emotional functioning after 8 weeks as well as momentary outcomes after meditating. Future large-scale trials should further assess the effectiveness of digital MBIs in this context. However, the findings suggest that digital MBIs might be promising and effective low-threshold add-on treatments in clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The article has been preregistered at ClinicalTrials.gov (identifier: NCT04769505, date: 23rd February 2021).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-025-03243-4","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:51:34Z","timestamp":1748227894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Digital mindfulness-based intervention for people with COPD \u2013 a multicentre pilot and feasibility RCT"],"prefix":"10.1186","volume":"26","author":[{"given":"Hannah","family":"Tschenett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Vafai-Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf Harun","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arschang","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg-Christian","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs M.","family":"Nater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"3243_CR1","first-page":"1289","volume":"9","author":"M Panagioti","year":"2014","unstructured":"Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J COPD. 2014;9:1289\u2013306.","journal-title":"Int J COPD"},{"key":"3243_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rmed.2016.06.006","volume":"117","author":"DL Matte","year":"2016","unstructured":"Matte DL, Pizzichini MMM, Hoepers ATC, Diaz AP, Karloh M, Dias M, Pizzichini E. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies. Respir Med. 2016;117:154\u201361.","journal-title":"Respir Med"},{"issue":"133","key":"3243_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1183\/09059180.00007813","volume":"23","author":"AM Yohannes","year":"2013","unstructured":"Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir J. 2013;23(133):345\u20139.","journal-title":"Eur Respir J"},{"issue":"1","key":"3243_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rehab.2016.09.002","volume":"60","author":"JC Chauvet-Gelinier","year":"2017","unstructured":"Chauvet-Gelinier JC, Bonin B. Stress, anxiety and depression in heart disease patients: A major challenge for cardiac rehabilitation. Ann Phys Rehabil Med. 2017;60(1):6\u201312.","journal-title":"Ann Phys Rehabil Med"},{"key":"3243_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.11.036","volume":"77","author":"JV Zorn","year":"2017","unstructured":"Zorn JV, Sch\u00fcr RR, Boks MP, Kahn RS, Jo\u00ebls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 2017;77:25\u201336.","journal-title":"Psychoneuroendocrinology"},{"key":"3243_CR6","doi-asserted-by":"crossref","unstructured":"Anden\u00e6s R, Kalfoss MH, Wahl AK. Coping and psychological distress in hospitalized patients with chronic obstructive pulmonary disease. Heart Lung J Acute Crit Care 2006 Jan-Feb;35(1):46\u201357.","DOI":"10.1016\/j.hrtlng.2005.09.009"},{"issue":"5","key":"3243_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/YCO.0b013e328363b4ed","volume":"26","author":"UM Nater","year":"2013","unstructured":"Nater UM, Skoluda N, Strahler J. Biomarkers of stress in behavioural medicine. Curr Opin Psychiatry. 2013;26(5):440\u20135.","journal-title":"Curr Opin Psychiatry"},{"issue":"79","key":"3243_CR8","first-page":"359","volume":"14","author":"A Van Gestel","year":"2012","unstructured":"Van Gestel A, Kohler M, Clarenbach C. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD). Discov Med. 2012;14(79):359\u201368.","journal-title":"Discov Med"},{"key":"3243_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2018.01.004","volume":"196","author":"S Singh","year":"2018","unstructured":"Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, Dixit RK. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett. 2018;196:1\u201310.","journal-title":"Immunol Lett"},{"issue":"2","key":"3243_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0893-133X(99)00129-3","volume":"22","author":"B McEwen","year":"2000","unstructured":"McEwen B. Allostasis and allostatic load implications for Neuropsychopharmacology. Neuropsychopharmacology. 2000;22(2):108\u201324.","journal-title":"Neuropsychopharmacology"},{"key":"3243_CR11","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report [Internet]. 2024. Available from: https:\/\/goldcopd.org\/2024-gold-report\/"},{"issue":"1","key":"3243_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000367635","volume":"84","author":"I Farver-Vestergaard","year":"2015","unstructured":"Farver-Vestergaard I, Jacobsen D, Zachariae R. Efficacy of psychosocial interventions on psychological and physical health outcomes in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Psychother Psychosom. 2015;84(1):37\u201350.","journal-title":"Psychother Psychosom"},{"issue":"8","key":"3243_CR13","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1007\/s12671-020-01348-z","volume":"11","author":"M Clari","year":"2020","unstructured":"Clari M, Conti A, Fontanella R, Rossi A, Matarese M. Mindfulness-based programs for people with chronic obstructive pulmonary disease: A mixed methods systematic review. Mindfulness. 2020;11(8):1848\u201367.","journal-title":"Mindfulness"},{"key":"3243_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-psych-042716-051139","volume":"68","author":"JD Creswell","year":"2017","unstructured":"Creswell JD. Mindfulness interventions. Annu Rev Psychol. 2017;68:491\u2013516.","journal-title":"Annu Rev Psychol"},{"key":"3243_CR15","doi-asserted-by":"crossref","unstructured":"Goldberg SB, Riordan KM, Sun S, Davidson RJ. The empirical status of mindfulness-based interventions: A systematic review of 44 meta-analyses of randomized controlled trials. Perspect Psychol Sci. 2022;(1):108\u201330.","DOI":"10.1177\/1745691620968771"},{"issue":"8","key":"3243_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/PSY.0000000000000970","volume":"83","author":"LMC Puhlmann","year":"2021","unstructured":"Puhlmann LMC, Vrti\u010dka P, Linz R, Stalder T, Kirschbaum C, Engert V, Singer T. Contemplative mental training reduces hair glucocorticoid levels in a randomized clinical trial. Psychosom Med. 2021;83(8):894\u2013905.","journal-title":"Psychosom Med"},{"issue":"3","key":"3243_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/PSY.0000000000000675","volume":"81","author":"JD Creswell","year":"2019","unstructured":"Creswell JD, Lindsay EK, Villalba DK, Chin B. Mindfulness training and physical health: mechanisms and outcomes. Psychosom Med. 2019;81(3):224\u201332.","journal-title":"Psychosom Med"},{"key":"3243_CR18","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.cpr.2021.102078","volume":"89","author":"H Taylor","year":"2021","unstructured":"Taylor H, Strauss C, Cavanagh K. Can a little bit of mindfulness do you good? A systematic review and meta-analyses of unguided mindfulness-based self-help interventions. Clin Psychol Rev. 2021;89:102078.","journal-title":"Clin Psychol Rev"},{"key":"3243_CR19","doi-asserted-by":"publisher","first-page":"175346662210754","DOI":"10.1177\/17534666221075493","volume":"16","author":"A Watson","year":"2022","unstructured":"Watson A, Wilkinson TMA. Digital healthcare in COPD management: A narrative review on the advantages, pitfalls, and need for further research. Ther Adv Respir Dis. 2022;16:175346662210754.","journal-title":"Ther Adv Respir Dis"},{"issue":"7","key":"3243_CR20","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s12671-024-02387-6","volume":"15","author":"H Tschenett","year":"2024","unstructured":"Tschenett H, Funk GC, Vafai-Tabrizi F, Nater UM. Patient perspectives on mindfulness-based interventions during hospitalization for acute exacerbations of chronic obstructive pulmonary disease: an exploratory interview study. Mindfulness. 2024;15(7):1638\u201349.","journal-title":"Mindfulness"},{"issue":"5","key":"3243_CR21","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.2196\/mhealth.9831","volume":"6","author":"OL Owens","year":"2018","unstructured":"Owens OL, Beer JM, Reyes LI, Gallerani DG, Amanda R. Mindfulness-based symptom and stress management apps for adults with chronic lung disease: systematic search in app stores. JMIR Mhealth Uhealth. 2018;6(5):e124.","journal-title":"JMIR Mhealth Uhealth"},{"key":"3243_CR22","doi-asserted-by":"publisher","first-page":"n2061","DOI":"10.1136\/bmj.n2061","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew M, Rycroft-Malone J, White M, Moore L. A new framework for developing and evaluating complex interventions: update of medical research Council guidance. BMJ. 2021;374:n2061.","journal-title":"BMJ"},{"issue":"1","key":"3243_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-016-0105-8","volume":"2","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA, O\u2019Cathain A, Altman D, Bretz F, Campbell M, Cobo E, Craig P, Davidson P, Groves T, Gumedze F, Hewison J, Hirst A, Hoddinott P, Lamb SE, Lang T, McColl E, Shanahan DR, Sutton C, Tugwell P. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2(1):1\u201332.","journal-title":"Pilot Feasibility Stud"},{"key":"3243_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/CLEP.S146397","volume":"10","author":"ML Bell","year":"2018","unstructured":"Bell ML, Whitehead AL, Julious SA. Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes. Clin Epidemiol. 2018;10:153\u20137.","journal-title":"Clin Epidemiol"},{"key":"3243_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"3243_CR26","volume-title":"Mindfulness-based cognitive therapy for depression","author":"ZV Segal","year":"2018","unstructured":"Segal ZV, Williams MT, Teasdale JD. Mindfulness-based cognitive therapy for depression. 2nd ed. New York: Guilford Press; 2018.","edition":"2"},{"issue":"2","key":"3243_CR27","doi-asserted-by":"publisher","first-page":"1702082","DOI":"10.1183\/13993003.02082-2017","volume":"51","author":"I Farver-Vestergaard","year":"2018","unstructured":"Farver-Vestergaard I, O\u2019Toole MS, O\u2019Connor M, Lokke A, Bendstrup E, Basdeo SA, Cox DJ, Dunne PJ, Ruggeri K, Early F, Zachariae R. Mindfulness-based cognitive therapy in COPD: A cluster randomised controlled trial. Eur Respir J. 2018;51(2):1702082.","journal-title":"Eur Respir J"},{"key":"3243_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12888-016-0875-9","volume":"16","author":"EM Klein","year":"2016","unstructured":"Klein EM, Br\u00e4hler E, Dreier M, Reinecke L, M\u00fcller KW, Schmutzer G, W\u00f6lfling K, Beutel ME. The German version of the perceived stress Scale - Psychometric characteristics in a representative German community sample. BMC Psychiatry. 2016;16:159\u2013159.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"3243_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648\u201354.","journal-title":"Eur Respir J"},{"issue":"4","key":"3243_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.rmed.2003.10.013","volume":"98","author":"MA Puhan","year":"2004","unstructured":"Puhan MA, Behnke M, Laschke M, Lichtenschopf A, Br\u00e4ndli O, Guyatt GH, Sch\u00fcnemann HJ. Self-administration and standardisation of the chronic respiratory questionnaire: A randomised trial in three German-speaking countries. Respir Med. 2004;98(4):342\u201350.","journal-title":"Respir Med"},{"issue":"3","key":"3243_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopsycho.2012.03.010","volume":"90","author":"T Stalder","year":"2012","unstructured":"Stalder T, Steudte S, Alexander N, Miller R, Gao W, Dettenborn L, Kirschbaum C. Cortisol in hair, body mass index and stress-related measures. Biol Psychol. 2012;90(3):218\u201323.","journal-title":"Biol Psychol"},{"issue":"2","key":"3243_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1348\/135910703321649169","volume":"8","author":"R Moss-Morris","year":"2003","unstructured":"Moss-Morris R, Petrie KJ. Experimental evidence for interpretive but not attention biases towards somatic information in patients with chronic fatigue syndrome. Br J Health Psychol. 2003;8(2):195\u2013208.","journal-title":"Br J Health Psychol"},{"key":"3243_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.psyneuen.2014.10.002","volume":"51","author":"N Skoluda","year":"2015","unstructured":"Skoluda N, Strahler J, Schlotz W, Niederberger L, Marques S, Fischer S, Thoma MV, Spoerri C, Ehlert U, Nater UM. Intra-individual psychological and physiological responses to acute laboratory stressors of different intensity. Psychoneuroendocrinology. 2015;51:227\u201336.","journal-title":"Psychoneuroendocrinology"},{"key":"3243_CR34","first-page":"825","volume":"126","author":"JGW Burdon","year":"1982","unstructured":"Burdon JGW, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982;126:825\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"3243_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2008","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2008;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"3243_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuron.2021.10.030","volume":"110","author":"Z Yu","year":"2022","unstructured":"Yu Z, Guindani M, Grieco SF, Chen L, Holmes TC, Xu X. Beyond t test and ANOVA: applications of mixed-effects models for more rigorous statistical analysis in neuroscience research. Neuron. 2022;110(1):21\u201335.","journal-title":"Neuron"},{"issue":"2","key":"3243_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1037\/1082-989X.12.2.121","volume":"12","author":"CK Enders","year":"2007","unstructured":"Enders CK, Tofighi D. Centering predictor variables in cross-sectional multilevel models: A new look at an old issue. Psychol Methods. 2007;12(2):121\u201338.","journal-title":"Psychol Methods"},{"key":"3243_CR38","doi-asserted-by":"crossref","unstructured":"Koller M. robustlmm: An R Package for Robust Estimation of Linear Mixed-Effects Models. J Stat Softw. 2016;75(6). Available from: http:\/\/www.jstatsoft.org\/v75\/i06\/","DOI":"10.18637\/jss.v075.i06"},{"key":"3243_CR39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/1357633X18780563","volume":"25","author":"I Farver-Vestergaard","year":"2018","unstructured":"Farver-Vestergaard I, O\u2019Connor M, Smith NC, L\u00f8kke A, Bendstrup E, Zachariae R. Tele-delivered mindfulness-based cognitive therapy in chronic obstructive pulmonary disease: A mixed-methods feasibility study. J Telemed Telecare. 2018;25:468\u201375.","journal-title":"J Telemed Telecare"},{"key":"3243_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/1479972318766140","volume":"15","author":"L Perkins-Porras","year":"2018","unstructured":"Perkins-Porras L, Riaz M, Okekunle A, Zhelezna S, Chakravorty I, Ussher M. Feasibility study to assess the effect of a brief mindfulness intervention for patients with chronic obstructive pulmonary disease: A randomized controlled trial. Chron Respir Dis. 2018;15:400\u201310.","journal-title":"Chron Respir Dis"},{"key":"3243_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.copsyc.2018.11.012","volume":"28","author":"AJ Mrazek","year":"2019","unstructured":"Mrazek AJ, Mrazek MD, Cherolini CM, Cloughesy JN, Cynman DJ, Gougis LJ, Landry AP, Reese JV, Schooler JW. The future of mindfulness training is digital, and the future is now. Curr Opin Psychol. 2019;28:81\u20136.","journal-title":"Curr Opin Psychol"},{"key":"3243_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/acm.2009.0037","volume":"15","author":"RA Mularski","year":"2009","unstructured":"Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W, Kim AC, Shekelle PG. Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease. J Altern Complement Med. 2009;15:1083\u201390.","journal-title":"J Altern Complement Med"},{"issue":"4","key":"3243_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jpainsymman.2019.01.009","volume":"57","author":"SB Tan","year":"2019","unstructured":"Tan SB, Liam CK, Pang YK, Leh-Ching Ng D, Wong TS, Wei-Shen Khoo K, Ooi CY, Chai CS. The effect of 20-minute mindful breathing on the rapid reduction of dyspnea at rest in patients with lung diseases: A randomized controlled trial. J Pain Symptom Manage. 2019;57(4):802\u20138.","journal-title":"J Pain Symptom Manage"},{"key":"3243_CR44","unstructured":"L\u00f6we B, Spitzer RL, Zipfel S, Herzog W. Gesundheitsfragebogen f\u00fcr Patienten (PHQ-D). Manual und Testunterlagen. 2. Aufl. Karlsruhe: Pfizer; 2002."}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03243-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03243-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T02:51:40Z","timestamp":1748227900000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03243-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03243-4","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in accordance with the Declaration of Helsinki, approved by the city of Vienna ethics review board (serial number: EK 20\u2013177 VK), and preregistered at ClinicalTrials.gov (identifier: NCT04769505). All participants provided written informed consent at baseline.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided consent for publication of their de-identified data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HT was employed as project assistant by the KLI and received lecture fees by Chiesi. GCF and AV are co-heads of the KLI. GCF received lecture fees by AstraZeneca, Boehringer Ingelheim, Chiesi, and Menarini Pharma. FVT received lecture fees by AstraZeneca, Chiesi, and Menarini Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}